International Union of Pharmacology. LXIII. Retinoid X receptors

被引:403
|
作者
Germain, Pierre
Chambon, Pierre
Eichele, Gregor
Evans, Ronald M.
Lazar, Mitchell A.
Leid, Mark
De Lera, Angel R.
Lotan, Reuben
Mangelsdorf, David J.
Gronemeyer, Hinrich
机构
[1] Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France
[2] Max Planck Inst Expt Endocrinol, Hannover, Germany
[3] Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA
[4] Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, Philadelphia, PA 19104 USA
[5] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA
[6] Oregon State Univ, Mol & Cellular Biol Program, Corvallis, OR 97331 USA
[7] Univ Vigo, Fac Quim, Dept Quim Organ, Vigo, Galicia, Spain
[8] Univ Texas, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Unit 432, Houston, TX 77030 USA
[9] Univ Texas, SW Med Ctr, Dept Pharmacol, Howard Hughes Med Inst, Dallas, TX USA
关键词
D O I
10.1124/pr.58.4.7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The physiological effects of retinoic acids (RAs) are mediated by members of two families of nuclear receptors, the retinoic acid receptors (RARs) and the retinoid X receptors (RXRs), which are encoded by three distinct human genes, RXR alpha, RXR beta, and RXR gamma. RARs bind both all-trans- and 9-cis-RA, whereas only the 9-cis-RA stereoisomer binds to RXRs. As RXR/RAR heterodimers, these receptors control the transcription of RA target genes through binding to RA-response elements. This review is focused on the structure, mode of action, ligands, expression, and pharmacology of RXRs. Given their role as common partners to many other members of the nuclear receptor superfamily, these receptors have been the subject of intense scrutiny. Moreover, and despite numerous studies since their initial discovery, RXRs remain enigmatic nuclear receptors, and there is still no consensus regarding their role. Indeed, multiple questions about the actual biological role of RXRs and the existence of an endogenous ligand have still to be answered.
引用
收藏
页码:760 / 772
页数:13
相关论文
共 50 条
  • [1] International Union of Pharmacology.: LXIV.: Estrogen receptors
    Dahlman-Wright, Karin
    Cavailles, Vincent
    Fuqua, Suzanne A.
    Jordan, V. Craig
    Katzenellenbogen, John A.
    Korach, Kenneth S.
    Maggi, Adriana
    Muramatsu, Masami
    Parker, Malcolm G.
    Gustafsson, Jan-Ake
    [J]. PHARMACOLOGICAL REVIEWS, 2006, 58 (04) : 773 - 781
  • [2] International Union of Pharmacology. LXVI. Orphan nuclear receptors
    Benoit, Gerard
    Cooney, Austin
    Giguere, Vincent
    Ingraham, Holly
    Lazar, Mitch
    Muscat, George
    Perlmann, Thomas
    Renaud, Jean-Paul
    Schwabe, John
    Sladek, Frances
    Tsai, Ming-Jer
    Laudet, Vincent
    [J]. PHARMACOLOGICAL REVIEWS, 2006, 58 (04) : 798 - 836
  • [3] International Union of Pharmacology. LX. Retinoic acid receptors
    Germain, Pierre
    Chambon, Pierre
    Eichele, Gregor
    Evans, Ronald M.
    Lazar, Mitchell A.
    Leid, Mark
    De Lera, Angel R.
    Lotan, Reuben
    Mangelsdorf, David J.
    Gronemeyer, Hinrich
    [J]. PHARMACOLOGICAL REVIEWS, 2006, 58 (04) : 712 - 725
  • [4] International union of pharmacology. XXIII. The angiotensin II receptors
    de Gasparo, M
    Catt, KJ
    Inagami, T
    Wright, JW
    Unger, T
    [J]. PHARMACOLOGICAL REVIEWS, 2000, 52 (03) : 415 - 472
  • [5] International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
    Howlett, AC
    Barth, F
    Bonner, TI
    Cabral, G
    Casellas, P
    Devane, WA
    Felder, CC
    Herkenham, M
    Mackie, K
    Martin, BR
    Mechoulam, R
    Pertwee, RG
    [J]. PHARMACOLOGICAL REVIEWS, 2002, 54 (02) : 161 - 202
  • [6] International union of pharmacology. XXII. Nomenclature for chemokine receptors
    Murphy, PM
    Baggiolini, M
    Charo, IF
    Hebert, CA
    Horuk, R
    Matsushima, K
    Miller, LH
    Oppenheim, JJ
    Power, CA
    [J]. PHARMACOLOGICAL REVIEWS, 2000, 52 (01) : 145 - 176
  • [7] International Union of Pharmacology. XXVIII. Proteinase-activated receptors
    Hollenberg, MD
    Compton, SJ
    [J]. PHARMACOLOGICAL REVIEWS, 2002, 54 (02) : 203 - 217
  • [8] International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors
    Fredholm, BB
    Ijzerman, AP
    Jacobson, KA
    Klotz, KN
    Linden, J
    [J]. PHARMACOLOGICAL REVIEWS, 2001, 53 (04) : 527 - 552
  • [9] International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors
    Caulfield, MP
    Birdsall, NJM
    [J]. PHARMACOLOGICAL REVIEWS, 1998, 50 (02) : 279 - 290
  • [10] International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
    Panula, Pertti
    Chazot, Paul L.
    Cowart, Marlon
    Gutzmer, Ralf
    Leurs, Rob
    Liu, Wai L. S.
    Stark, Holger
    Thurmond, Robin L.
    Haas, Helmut L.
    [J]. PHARMACOLOGICAL REVIEWS, 2015, 67 (03) : 601 - 655